Argenx Se ADR (ARGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARGX | GSK | ALNY | ||
| Company | Argenx Se ADR | Gsk Plc ADR | Alnylam Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 587.39 | 33.40 | 247.46 | ||
| High | 601.95 | 33.70 | 250.71 | ||
| Low | 582.07 | 33.18 | 245.32 | ||
| Last | 596.74 | 33.70 | 246.80 | ||
| Change | +4.92 | +0.35 | -1.99 | ||
| % Change | +0.83% | +1.05% | -0.80% | ||
| Volume | 417,700 | 7,030,600 | 687,200 | ||
| 20-Day Average Volume | 325,220 | 8,395,450 | 979,310 | ||
| Previous Close | 591.82 | 33.35 | 248.79 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 581.89 | 35.80 | 265.27 | ||
| 20-Day Raw Stochastic | 77.95% | 16.11% | 26.52% | ||
| 20-Day Relative Strength | 59.09% | 30.55% | 40.55% | ||
| Weighted Alpha | +38.82 | -15.44 | +21.66 | ||
| Today's Opinion | 100% Buy | 100% Sell | 8% Buy | ||
| Previous Opinion | 96% Buy | 100% Sell | 24% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.29% since 11/14/24 | -2.01% since 11/14/24 | -4.31% since 11/14/24 | ||
| Low | 558.15 on 11/19/24 | 32.83 on 11/15/24 | 229.85 on 11/18/24 | ||
| High | 601.95 on 11/21/24 | 33.79 on 11/18/24 | 254.17 on 11/15/24 | ||
| 1-Month | |||||
| %Chg | +6.48% since 10/21/24 | -11.69% since 10/21/24 | -15.48% since 10/21/24 | ||
| Low | 545.55 on 10/30/24 | 32.83 on 11/15/24 | 229.85 on 11/18/24 | ||
| High | 611.22 on 11/05/24 | 38.26 on 10/29/24 | 301.05 on 10/24/24 | ||
| 3-Month | |||||
| %Chg | +13.56% since 08/21/24 | -19.47% since 08/21/24 | -11.60% since 08/21/24 | ||
| Low | 511.19 on 08/27/24 | 32.83 on 11/15/24 | 229.85 on 11/18/24 | ||
| High | 611.22 on 11/05/24 | 44.67 on 08/27/24 | 304.39 on 10/17/24 | ||
| 6-Month | |||||
| %Chg | +67.31% since 05/21/24 | -24.20% since 05/21/24 | +64.95% since 05/21/24 | ||
| Low | 358.80 on 05/24/24 | 32.83 on 11/15/24 | 146.79 on 05/30/24 | ||
| High | 611.22 on 11/05/24 | 45.79 on 05/22/24 | 304.39 on 10/17/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 35,388,472 | 69,119,536 | 32,089,182 | ||
| Shares Outstanding, K | 59,796 | 2,072,550 | 128,981 | ||
| Annual Sales | 1,268,590,000 | 37,725,000,000 | 1,828,290,000 | ||
| Annual Net Income | -295,050,000 | 6,129,940,000 | -440,240,000 | ||
| Last Quarter Sales | 588,880,000 | 10,420,410,000 | 500,920,000 | ||
| Last Quarter Net Income | 91,410,000 | -75,430,000 | -111,570,000 | ||
| 60-Month Beta | 0.61 | 0.66 | 0.39 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.39 on 10/31/24 | 1.27 on 10/30/24 | -0.50 on 10/31/24 | ||
| Latest Earnings Date | 10/31/24 | 10/30/24 | 10/31/24 | ||
| Most Recent Dividend | N/A | 0.382 on 11/15/24 | N/A | ||
| Next Ex-Dividends Date | N/A | 11/15/24 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 8.02 | 0.00 | ||